Ribozyme-targeted destruction of RNA associated with autosomal-dominant retinitis pigmentosa

Investigative Ophthalmology and Visual Science

Volumn 39, Issue 5, 1998, Pages 681-689

  Drenser, Kimberly A ^a   Timmers, Adrian M ^a   Hauswirth, William W ^a   Lewin, Alfred S ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; RIBOZYME; RNA;

ANIMAL TISSUE; ARTICLE; AUTOSOMAL DOMINANT DISORDER; ENZYME ACTIVITY; ENZYME SUBSTRATE; GENE MUTATION; GENE THERAPY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; RETINA DEGENERATION; RETINA DISEASE; RETINITIS PIGMENTOSA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ELECTROPHORESIS, POLYACRYLAMIDE GEL; KINETICS; OLIGONUCLEOTIDE PROBES; OPSIN; PLASMIDS; POLYMERASE CHAIN REACTION; RATS; RETINITIS PIGMENTOSA; RNA; RNA, CATALYTIC; RNA, MESSENGER; RODS (RETINA); TRANSCRIPTION, GENETIC;

EID: 0031965901     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Berson EL. Retinitis pigmentosa: unfolding its mystery. Proc Natl Acad Sci USA. 1996;93:4526-4528.
2. Huang PC, Gaitan AE, Petters RM, Wong F. Cellular interactions implicated in the mechanism of photoreceptor degeneration in transgenic mice expressing a mutant rhodopsin gene. Proc Natl Acad Sci USA. 1993;90:8484-8488.
3. Roof DJ, Adamian M, Hayes A. Rhodopsin accumulation at abnormal sites in retinas of mice with a human P23H rhodopsin transgene. Invest Ophthalmol Vis Sci. 1994;35:4049-4062.
4. Colley NJ, Cassill JA, Baker EK, Zuker CS. Defective intracellular transport is the molecular basis of rhodopsin-dependent dominant retinal degeneration. Proc Natl Acad Sci USA. 1995;92:3070-3074.
5. Deretic D, Huber LA, Ransom N, Mancini M, Simons K, Papermaster DS. Rab8 in retinal photoreceptors may participate in rhodopsin transport and in rod outer segment disk morphogenesis. J Cell Sci. 1995;108:215-224.
6. Li T, Snyder WK, Olsson JE, Dryja TP. Transgenic mice carrying the dominant rhodopsin mutation P347S: evidence for the defective vectorial transport of rhodopsin to the outer segments. Proc Natl Acad Sci USA. 1996;93:14176-14181.
7. Li T, Franson WK, Gordon JW, Berson EL, Dryja TP. Constitutive activation of phototransduction by K296E opsin is not a cause of photoreceptor degeneration. Proc Natl Acad Sci USA. 1995;92: 3551-3555.
8. Liu X, Garriga P, Khorana HG. Structure and function in rhodopsin: correct folding and misfolding in the intradiscal domain of rhodopsin identified in retinitis pigmentosa. Proc Natl Acad Sci USA. 1996;93:4554-4559.
9. Protera-Cailliau C, Sung C-H, Nathans J, Adler R. Apoptotic photoreceptor cell death in mouse models of retinitis pigmentosa. Proc Natl Acad Sci USA. 1994;91:974 -978.
10. Rosenfeld PJ, Dryja TP. Molecular genetics of retinitis pigmentosa and related retinal degenerations. Molecular Genetics of Ocular Disease. Wiggs JL, ed. New York: Wiley-Liss; 1995:99-126.
11. Sung C-H, Davenport CM, Hennessey JC, et al. Rhodopsin mutations in autosomal dominant retinitis pigmentosa. Proc Natl Acad Sci USA. 1991;88:6481-6485.
12. Lem J, Makino CL. Phototransduction in transgenic mice. Curr Opin Neurobiol. 1996;6:453-458.
13. Naash MI, Hollyfield JG, Al-Ubaidi MR, Baehr W. Simulation of human autosomal dominant retinitis pigmentosa in transgenic mice expressing a mutated murine opsin gene. Proc Natl Acad Sci USA. 1993;90:5499-5503.
14. Nishikawa S, Cao W, Yasamura D, et al. Comparing the ERG to retinal morphology in transgenic rats with inherited degenerations caused by mutant opsin genes [ARVO Abstract]. Invest Ophthalmol Vis Sci. 1997;38:S148.
15. Olsson JE, Gordon JW, Pawlyk BS, Roof D, Hayes A, Molday RS, Mukai S, Cowley GS, Berson EL, Dryja TP. Transgenic mice with a rhodopsin mutation (Pro23His) - a mouse model of autosomal dominant retinitis pigmentosa. Neuron. 1992;9:815-830.
16. Gesteland RE, Atkins JF, eds. The RNA World. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1993:1-630.
17. Liu F, Altman S. Inhibition of viral gene expression by the catalytic RNA subunit of RNAse P from Escherichia colt. Genes Devel. 1995;9:471-480.
18. Sullenger BA, Cech TR. Ribozyme mediated repair of defective mRNA by targeted trans-splicing. Nature. 1994;371:619-622.
19. Birikh KR, Heaton PA, Eckstein F. The structure, function and application of the hammerhead ribozyme. EurJ Biochem. 1997; 245:1-16.
20. Ruffner DE, Stormo GD, Uhlenbeck OC. The sequence requirements of the hammerhead self-cleavage reaction. Biochemistry. 1990;29:10695-10702.
21. Crisell P, Thompson S, James W. Inhibition of HIV-1 replication by ribozymes that show poor activity in vitro. Nucleic Acids Res. 1993;21:5251-5255.
22. Ferbeyre G, Bratty J, Chen H, Cedegren R. A hammerhead ribozyme inhibits ADE1 gene expression in yeast. Gene. 1995;155: 45-50.
23. Koizumi M, Kamiya H, Ohtsuka E. Ribozymes designed to inhibit transformation of NIH3T3 cells by the activated c-Ha-ras gene. Gene. 1992:177:179-184.
24. L'Huillier PJ, Soulier S, Stinnakre M-G, et al. Efficient and specific ribozyme-mediated reduction of bovine α-lactalbumin expression in double transgenic mice. Proc Natl Acad Sci USA. 1996;93: 6698-6703.
25. Kijima H, Ishida H, Ohkawa T, Kashani-Sabet M, Scanlon KJ. Therapeutic applications of ribozymes. Pharmacol Ther. 1995;68: 247-267.
26. Pachuk CJ, Yoon K, Morlling K, Cone LR. Selective cleavage of bcr-abl chimeric RNAs by a ribozyme targeted to non-contiguous sequences. Nucleic Acids Res. 1994;22:301-307.
27. Tang X-B, Hobom G, Luo D. Ribozyme mediated destruction of influenza A virus in vitro and in vivo. J Med Virol. 1994;42:385-395
28. Yamada O, Kraus G, Leavitt M C, Yu M, Wong-Staal F. Activity and cleavage site specificity of an anti-HIV hairpin ribozyme in human T cells. Virology. 1994;205:121-126.
29. Hampel A, Tritz R, Hicks M, Cruz P. Hairpin catalytic RNA model: evidence for helices and sequence requirement for substrate RNA. Nucleic Acids Res. 1990;18:299-304.
30. Butcher SE. Structure-mapping of the hairpin ribozyme. J Mol Biol. 1994;244:52-63.
31. McCall MJ, Hendry P, Jennings PA. Minimal sequence requirements for ribozyme activity. Proc Natl Acad Sci USA. 1992;89: 5710-5714.
32. Dahm SC, Uhlenbeck OC. Role of divalent metal ions in the hammerhead RNA cleavage reaction. Biochemistry. 1991;30: 9464-9469.
33. Pyle AM. Ribozymes: a distinct class of metalloenzymes. Science. 1993;261:709-714.
34. Scott WG, Klug A. Ribozymes: structure and mechanism in RNA catalysis. Trends Biochem Sci. 1996;21:885-888.
35. Joseph S, Berzal-Herranz A, Chowrira BM, Butcher SE, Burke JM. Substrate selection rules for the hairpin ribozyme determined by in vitro selection, mutation, and analysis of mismatched substrates. Gene Dev. 1993;7:130-138.
36. Shimayama T, Nishikawa S, Taira K. Generality of the NUX rule: kinetic analysis of the results of systematic mutations in the trinucleotde at the cleavage site of hammerhead ribozymes. Biochemistry. 1995;34:3649-3654.
37. Ohguro H, Rudnicka-Nawrot M, Buczylko J, Zhao X, Taylor JA. Structural and enzymatic aspects of rhodopsin phosphorylation. J Biol Chem. 1996;9:5215-5224.
38. Lohse MJ, Krasel C, Winstel R, Mayor F Jr. G-protein-coupled receptor kinases. Kidney Int. 1996;49:1047-1052.
39. Phillips WJ, Cerione RA. A C-terminal peptide of bovine rhodopsin binds to the transducins 34 a-subunit and facilitates its activation. Biochem J. 1994;299:351-357.
40. Altschuler M, Tritz R, Hampel AA. Method for generating transcripts with denned 5′ and 3′ termini by autolytic processing. Gene. 1992;122:85-90.
41. Berzal-Herranz A, Joseph S, Chowrira BM, Butcher SE, Burke JM. Essential nucleotide sequences and secondary structure elements of the hairpin ribozyme. EMBO J, 1993;12:2567-2573.
42. Anderson P, Monforte J, Tritz R, Nesbitt S, Hearst J, Hampel A. Mutagenesis of the hairpin ribozyme. Nucleic Acids Res. 1994;22: 1096-1100.
43. Esteban JA, Banerjee AR, Burke JM. Kinetic mechanism of the hairpin ribozyme. J Biol Chem. 1997;272:13629-13639.
44. Hegg LA, Fedor MJ. Kinetics and thermodynamics of intermolecular catalysis by hairpin ribozymes. Biochemistry. 1995;34:15813-15828.
45. Jankowsky E, Schwenzer B. Oligonucleotide facilitators may inhibit or activate a hammerhead ribozyme. Nucleic Acids Res. 1996; 24:423-429.
46. Jaeger JA, Turner DH, Zuker M. Improved predictions of secondary structures for RNA. Proc Natl Acad Sci USA. 1989;86:7706-7710.
47. Geller AM, Sieving PA, Green DG. Effect on grating identification of sampling with degenerate arrays. J Opt Soc Am. 1992;9:472-477.
48. Flannery JG, Zolotukhin S, Vaquero MI, LaVail MM, Muzyczka N, Hauswirth WW. Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus. Proc Natl Acad Sci USA. 1997;94:6916-6921.
49. Freier SM, Kierzek R, Jaeger JA, et al. Improved free-energy parameters for predictions of RNA duplex stability. Proc Natl Acad Sci USA. 1986;83:9373-9377.
50. Koizumi M, Hayase Y, Iwai S, Kamiya H, Inoue H, Ohtsuka E. Design of RNA enzymes distinguishing a single base mutation in RNA. Nucleic Acids Res. 1989;17:7059-7071.
51. Albery WJ, Knowles JR. Evolution of enzyme function and the development of catalytic efficiency. Biochemistry. 1976;15:5631-5640.
52. Pley HW, Flaherty KM, McKay DB. Three-dimensional structure of a hammerhead ribozyme. Nature. 1994;372:68-74.
53. Beelman CA, Parker R. Degradation of mRNA in eukaryotes. Cell. 1995;81:179-183.
54. Heidenreich O, Kang S-H, Brown DA, et al. Ribozyme-mediated RNA degradation in nuclei suspension. Nucleic Acids Res. 1995; 23:2223-2228.